Past Events

For more information on cluster activities and events, please email Jeff LeDue at jledue@mail.ubc.ca.

Amyloid plaques in the brain.
Steering an enzyme’s “scissors” shows potential for stopping Alzheimer’s disease Jul 19, 2017

The old real estate adage about “location, location, location” might also apply to the biochemical genesis of Alzheimer’s disease, according to new research.

Scientists at the Djavad Mowafaghian Centre for Brain Health have identified a couple of crucial steps in the formation a protein called amyloid beta, which accumulates in clumps, or “plaques,” in the brains of people with Alzheimer’s disease. Those discoveries inspired efforts at disrupting the biochemical carving of amyloid beta’s precursor protein into its final, toxic shape.

+
What artificial intelligence can learn from the human brain
What AI can learn from the brain and vice-versa: An evening with Dr. Gary Marcus Jun 9, 2017

According to Dr. Gary Marcus, world-renowned cognitive neuroscientist, bestselling author, and Founder of Geometric Intelligence, recently acquired by Uber, the future of artificial intelligence (AI) is tied to innovations in neuroscience. As our understanding of the brain evolves over the next decade or more, so will our ability to digitally reverse-engineer the brain.

+
Santiago Ramón y Cajal, injured Purkinje neurons, 1914, ink and pencil on paper. Courtesy of Instituto Cajal (CSIC).
Drawings of Santiago Ramón y Cajal to be shown at UBC Apr 13, 2017

Pictured: Santiago Ramón y Cajal, injured Purkinje neurons, 1914, ink and pencil on paper. Courtesy of Instituto Cajal (CSIC).

+
Carles Vilarino-Guell
Researchers find genetic cause of multiple sclerosis Jun 1, 2016

The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.

+
Older man thinking
Newly discovered biomarker offers genetic predictor of dementia in Parkinson disease May 24, 2016

For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.

+
Circle of young children
Gut microbes associated with early onset pediatric MS May 16, 2016

Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children with MS.

+
Trainee Profile: Dr. Simon Chen Apr 21, 2016

"In Dr. Haas’ lab, we identified the involvement of the transcription factor MEF2 in regulating metaplasticity by accident. The finding was totally unexpected," says Dr. Simon Chen, who completed his PhD in Dr. Kurt Haas’ lab at UBC. Dr.

+
UBC showcases its strengths as neurologists meet in Vancouver Apr 14, 2016

As 12,000 neurologists descend on Vancouver for the American Academy of Neurology’s 68th annual meeting this week, the Djavad Mowafaghian Centre for Brain Health is poised to make the most of the opportunity to showcase our clinical and scientific leadership in the field.

Three Centre members will be giving talks at plenary sessions the world’s largest gathering of neurologists, taking place at the Vancouver Convention Centre April 15-21:

+
APEC collaboration to address the economic burden of mental illness Apr 11, 2016

On April 13, 2016, the World Bank and the World Health Organization will co-host their first-ever high-level meeting on mental health and economic prosperity in Washington, DC. According to the World Bank, the meeting  “aims to move mental health from the margins to the mainstream of the global development agenda” and will bring together finance ministers, inter-governmental organizations, and business, academic, and civic leaders to promote critical investments in mental health around the globe.

+
New Medical Manager for Alzheimer and dementia clinic Apr 8, 2016

The UBC Hospital Clinic for Alzheimer Disease and Related Disorders (UBCH CARD) announced this week that Dr. Haakon Nygaard has been appointed to the role of Medical Manager of the clinic. Located within the Djavad Mowafaghian Center for Brain Health at the UBC Hospital, the clinic was under the leadership of Dr. Howard Feldman until his departure from UBC in March.

+

Pages